Can we use pre-therapy PSMA PET/CT as apredictor for Lutetium-177-PSMA-617 therapy-Early experience from the Canadian CancerTrials Group PR21 trial (NCT 04663997)

Category Primary study
JournalJournal of Nuclear Medicine
Year 2023
This article has no abstract
Epistemonikos ID: cc56ec3d98e13286ba3e549dc3e8186013163a0e
First added on: Feb 17, 2025